GlobeNewswire Inc.··Not SpecifiedNeutrolis Bolsters Leadership with Seasoned Biotech Veteran Deardorf as Chief Strategy Officer
Clinical-stage biotech Neutrolis appoints Caren Deardorf as Chief Business & Strategy Officer, bringing 30 years of pharma commercialization expertise as company advances NTR-1011 candidate.
EDITCRNXautoimmune diseasescommercialization